IMMUNESYSTEM
Conditions
Interventions
Group 1: The first arm describes the conduction of a single bout of 45-minute endurance exercise on a cycle ergometer. Following a three-minute warm-up period with 50 Watts, the trainings period is in
Sponsors
Institute for Cardiovascular Research and Sports Medicine
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: healthy ,sport students
Exclusion criteria
Exclusion criteria: Operated, under strong medication, performance athletes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study is the amino acid Tryptophan, its metabolites Kynurenine and Kynurenine Acid as well as the cytokines Interleukin-6 and Interferon-?. The determination of the outcomes is conducted through the blood analysis before (T0), immediately after (T1) and one hour after (T2) the completion of the exercise sessions. | — |
Secondary
| Measure | Time frame |
|---|---|
| As secondary outcomes, blood and lipid profile as well as PBMCs (Peripheral Blood Mononuclear Cells) will be measured before (T0), immediately after (T1) and one hour after (T2) the completion of the exercise sessions. | — |
Countries
Germany
Contacts
Public ContactChristina Koliamitra
Institute for Cardiovascular Research and Sports Medicine
Outcome results
None listed